Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07667166

Composite Index for Outcome Burden in Acute Cholangitis

The goal of this retrospective observational study is to construct a composite outcome to measure the success of treatment in patients who are presenting with acute cholangitis (blockage and infection of bile ducts) and undergoing a drainage procedure with different modalities. The study is not intended to test any predetermined hypothesis and does not have any comparison group. The participants' data are collated from retrospective hospital records and analysed for the purpose of the study. All the procedures are in place to ensure the confidentiality of the study participants while collating, analysing and sharing study findings.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Asian Institute of Gastroenterology Pvt Ltd (AIG Hospitals)

Hyderabad, Telangana, 500032, India

Location status: Recruiting

Location contact

Dr.Duvvur Nageshwar Reddy

SUB_INVESTIGATOR

Hardik Rughwani

CONTACT

[email protected]

+919426928600

Hardik Rughwani

PRINCIPAL_INVESTIGATOR

Nitin Jagtap

SUB_INVESTIGATOR

About this study

Study Aim To develop and internally validate a Composite Index that summarizes overall outcome burden in patients with acute cholangitis.

Primary Objective (Index Development)

  • To derive a Multidimensional Composite Index for Outcome Burden among patients with acute Cholangitis undergoing Biliary Drainage, that inegrates
  • Mortality (30-day and in-hospital)
  • Organ support,
  • ICU admission and ICU length of stay,
  • Complication burden and severity (AGREE and Clavien-Dindo classification as applicable),
  • Hospital length of stay,
  • 30-day reintervention
  • 30-day readmission.

Secondary Objectives

  • To evaluate the association of the Composite Index with:
  • TG18 severity grade (I vs II vs III),
  • Baseline physiological/lab derangement (WBC, bilirubin, creatinine, lactate),
  • To explore whether timing of biliary drainage is associated with composite index scores (exploratory-hypothesis-generating).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 to 80 years
  • Hospital admission with definite diagnosis of acute cholangitis meeting TG18 diagnostic criteria
  • TG18 Grade I (Mild) Grade II (moderate) or Grade III (severe) at presentation/admission or prior to drainage.
  • Underwent biliary drainage attempt (ERCP/PTBD/EUS-BD) or were planned for drainage (including failures with rescue drainage).
  • First episode of index BD in case of patients undergoing multiple episodes of index BD as per operational definitions (Technical supplement 1)
  • Planned repeat BD in same admission shall be considered as continuation of the index BD and all the procedural details shall be documented and analysed.

Exclusion criteria

  • Pregnant women
  • Missing key outcome data (minimum required: mortality status + ICU admission status + Length of stay)
  • Non-biliary sepsis without evidence of biliary obstruction/infection on review.
  • A patients with past history of BD outside the study setting (As this is akin to second episode of Index BD)
  • Subsequent episodes of Index BD (other than the first index BD episode) among patients with more than one episode of Index BD.

Treatment and study plan

Biliary drainage

Procedure

Underwent biliary drainage attempt (ERCP/PTBD/EUS-BD) or were planned for drainage (including failures with rescue drainage)

Other names: ERCP, PTBD, EUS BD

Primary outcomes

  1. Multidimensional Composite Index for Outcome Burden among patients with acute Cholangitis undergoing Biliary Drainage

    Time frame: 30 days

    To derive a Multidimensional Composite Index for Outcome Burden among patients with acute Cholangitis undergoing Biliary Drainage, that integrates mortality (30-day and in-hospital), organ support, ICU admission and ICU length of stay, complication burden and severity (AGREE and Clavien-Dindo classification as applicable), hospital length of stay, 30-day reintervention and 30-day readmission.

Study contacts

Contact information is provided by the study sponsor or research team.

Hardik Hardik Rughwani

CONTACT

[email protected]

+919426928600

Sponsors and collaborators

Lead sponsor

Asian Institute of Gastroenterology, India

Other

Collaborators

  • Christian Medical College, Vellore, India
  • Medanta, The Medicity, India
  • SIDS Hospital and Research Center, Surat

Registry information

Official study title

Development and Internal Validation of a Multidimensional Composite Index for Outcome Burden in Acute Cholangitis: A Multicentre Retrospective Cohort Study in India

Acronym: CHOLINDEX-01

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jun 24, 2026
Registry last updated
Jun 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.